Drug Profile
Birch pollen allergen extract - Allergopharma
Alternative Names: AL-0206stLatest Information Update: 05 Apr 2013
Price :
$50
*
At a glance
- Originator Biomay
- Class Allergens; Peptide vaccines; Peptides; Skin disorder therapies; Tree pollen allergy immunotherapies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Seasonal allergic rhinitis
Most Recent Events
- 05 Apr 2013 No development reported - Phase-II for Seasonal allergic rhinitis in Germany (Sublingual)